Clinical Trial to Study the COVAC-2 Booster Dose (for COVID-19) in Generally Healthy Adults.

NCT05226702 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

60

Enrollment

OTHER

Sponsor class

Conditions

Double Vaccinated for COVID-19 (For Phase 1 of the Study)
Acute Respiratory Syndrome Coronavirus 2 (For Phase 2 Exploratory Group)

Interventions

BIOLOGICAL: COVAC-2
BIOLOGICAL: Saline Placebo

Sponsor

University of Saskatchewan

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]